Regard
Aino-AI ANS: Leveraging AI for accurate patient diagnosis and doctor note generation.
Aino-AI ANS: Leveraging AI for accurate patient diagnosis and doctor note generation.
Regard, originally known as Aino-AI ANS, was founded with the mission to leverage artificial intelligence to enhance patient care and reduce physician burnout. The company offers AI-driven solutions that automatically diagnose patients and generate accurate medical notes, thereby streamlining clinical workflows. Their products are embedded within Electronic Health Records (EHR) systems, enabling clinicians and administrators to capture revenue more efficiently and focus on patient care. Regard primarily targets healthcare providers looking to optimize their clinical tasks and improve diagnostic accuracy.
Notable figures associated with Regard include its founding team of healthcare professionals and AI experts who have driven the company's innovative approach. The startup has attracted significant investment from leading venture capital firms in the health tech space, underscoring its potential for impact. Key achievements include successful integrations with major EHR systems and positive feedback from early adopters in the medical community. Overall, Regard has made a substantial impact by enhancing the efficiency and accuracy of clinical practices, contributing to better patient outcomes and reduced physician workload.
Companies similar to Regard include Retina-Ai Health, Augmedix, RAD AI and Notable Health.
Regard was founded in 2017.
Regard's headquarters is located in Los Angeles, CA, US.
Regard's most recent funding round was for $15.3M (USD) in June 2022.
As of Jun 29, 2022, Regard has raised a total of $20.4M (USD).
Regard has 66 employees as of Feb 4, 2024.
RAD AI
radai.com
